mProX™ Human DDR2 Stable Cell Line
- Product Category:
- Membrane Protein Stable Cell Lines
- Subcategory:
- Kinase Cell Lines
To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.
Lot Number
Made to Order Inquiry
InquiryProduct Information
Product Properties
Protocols
Please visit our protocols page.
Customer Reviews
Ashley
Verified Customer
Gary
Verified Customer
Any questions about our products? Please visit our frequently asked questions page.
Published Data
Fig.1 The expression of DDR2 in cell lines and HCC tissues.
Using qRT-PCR, DDR2 mRNA expression was measured in five hepatoma cell lines (MHCC-97H, HepG2, Huh-7, Hep3B, and SMMC-7721) and the immortalized normal human liver cell line L-02.
Ref: Xie, Binhui, et al. "DDR2 facilitates hepatocellular carcinoma invasion and metastasis via activating ERK signaling and stabilizing SNAIL1." Journal of Experimental & Clinical Cancer Research 34.1 (2015): 1-13.
Pubmed: 26362312
DOI: 10.1186/s13046-015-0218-6
Research Highlights
DDR2 is positively linked and overexpressed in GC patients with adverse clinical characteristics. Through mTORC2 activation and AKT phosphorylation, DDR2 facilitates the EMT process, which in turn promotes tumor growth and invasion.
Wang, Yu-Gang, et al. "DDR2 induces gastric cancer cell activities via activating mTORC2 signaling and is associated with clinicopathological characteristics of gastric cancer." Digestive diseases and sciences 61 (2016): 2272-2283.
Pubmed:
27010547
DOI:
10.1007/s10620-016-4116-3
Targeted small molecule inhibitors are not effective in treating most nonsmall cell lung cancers (NSCLCs), despite ten years of progress in precision medicine techniques. Previous research has revealed that Discoidin Domain Receptor 2 (DDR2) kinase mutations may be useful therapeutic targets in non-small cell lung cancers.
Terai, Hideki, et al. "Characterization of DDR2 inhibitors for the treatment of DDR2 mutated nonsmall cell lung cancer." ACS chemical biology 10.12 (2015): 2687-2696.
Pubmed:
26390252
DOI:
10.1021/acschembio.5b00655